BioTheryX Announces FDA Approval of IND Application to Initiate Phase 1 Clinical Trial in Relapsed or Refractory Acute Myeloid Leukemia

2021-05-19T16:04:39-07:00May 29, 2019|

Expect Enrollment of Phase 1 Trial to Begin in the Third Quarter of 2019 CHAPPAQUA, N.Y., May 29, 2019 [...]